Tranexamic Acid Tablet
Product Images NDC 60687-750

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 60687-750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp75021

Ahp75021
Tranexamic Acid 650 mg oral tablet shown as an oblong, white or off-white pill. The tablet features the imprint 'AMG 229' on one side and is plain on the other. The image highlights the physical appearance of this prescription drug by American Health Packaging.*
FDA Label Image

650 mg Tranexamic Acid Tablet Blister (Blister)

650 mg Tranexamic Acid Tablet Blister (Blister)
The image shows multiple identical labels for Tranexamic Acid tablets USP, each with a strength of 650 mg. The labels include barcodes and expiration and lot number placeholders. The product is labeled by American Health Packaging, located in Columbus, Ohio, and includes the NDC number 60687-750-11.*
FDA Label Image

650 mg Tranexamic Acid Tablets Carton (Carton)

650 mg Tranexamic Acid Tablets Carton (Carton)
Tranexamic Acid Tablets USP 650 mg oral tablets packaging label, showing a 30 tablet count (3 blister packs of 10), from American Health Packaging. The label includes dosage strength, NDC 60687-750-21, pharmacist instructions, storage conditions, and distribution information.*
FDA Label Image

Figure 1: Menstrual Bleeding Loss Levels Over Duration Of Therapy In Women With Heavy Menstrual Bleeding (studies 1 And 2) (Figure1)

Figure 1: Menstrual Bleeding Loss Levels Over Duration Of Therapy In Women With Heavy Menstrual Bleeding (studies 1 And 2) (Figure1)
Line graph depicting mean menstrual blood loss (mL) over treatment periods for Tranexamic Acid Tablets 3900 mg/day and placebo in 3-cycle and 6-cycle studies. The x-axis shows treatment periods from baseline through six cycles, and the y-axis shows mean blood loss in mL, illustrating changes in blood loss across treatment cycles for both groups.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure diagram of Tranexamic Acid showing a cyclohexane ring with attached amino and carboxyl functional groups, consistent with the 650 mg oral tablet formulation by American Health Packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.